{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:37:50Z","timestamp":1782603470290,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.contraception.2009.02.016","type":"journal-article","created":{"date-parts":[[2009,5,10]],"date-time":"2009-05-10T04:16:30Z","timestamp":1241928990000},"page":"25-33","source":"Crossref","is-referenced-by-count":36,"title":["Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara\u00ae) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial"],"prefix":"10.1016","volume":"80","author":[{"given":"Gerd","family":"Plewig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Cunliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"H\u00f6schen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2009.02.016_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00044011-200222040-00002","article-title":"Contraceptive efficacy and tolerability of chlormadinone acetate 2 mg\/ethinylestradiol 0.03 mg (Belara\u00ae). Results of a post-marketing surveillance study","volume":"22","author":"Schramm","year":"2002","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.contraception.2009.02.016_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/00016348609157049","article-title":"Cyproterone acetate versus levonorgestrel combined with ethinyl estradiol in the treatment of acne. Results of a multicenter study","volume":"134","author":"Carlborg","year":"1986","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"10.1016\/j.contraception.2009.02.016_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1055\/s-2008-1036324","article-title":"Effect of a new hormonal contraceptive (Neo-Eunomin) in females with androgenization symptoms","volume":"44","author":"Kaiser","year":"1984","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1016\/j.contraception.2009.02.016_bib4","series-title":"Hirsutism","author":"Breckwoldtt","year":"1990"},{"key":"10.1016\/j.contraception.2009.02.016_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0303-7207(02)00377-5","article-title":"Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line","volume":"198","author":"Terouanne","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.contraception.2009.02.016_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2165\/00003495-200464070-00005","article-title":"Ethinylestradiol\/chlormadinone acetate","volume":"64","author":"Curran","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2009.02.016_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0010-7824(98)00008-0","article-title":"Efficacy and safety of the new antiandrogenic oral contraceptive Belara","volume":"57","author":"Zahradnik","year":"1998","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.02.016_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0010-7824(02)00536-X","article-title":"A 12-month evaluation of the CMA-containing oral contraceptive Belara: efficacy, tolerability and anti-androgenic properties","volume":"67","author":"Schramm","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.02.016_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/13625189909040809","article-title":"A comparative study of the hemostatic effects of two monophasic oral contraceptives containing 30 mu(g) ethinylestradiol and either 2 mg chlormadinone acetate or 150 mu(g) desogestrel","volume":"4","author":"Winkler","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.02.016_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000051701","article-title":"Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE\/CMA (Belara) and EE\/LNG (Microgynon)","volume":"203","author":"Worret","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.contraception.2009.02.016_bib11","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.115.5.571","article-title":"An acne grading method using photographic standards","volume":"115","author":"Cook","year":"1979","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.contraception.2009.02.016_bib12","unstructured":"ICH Topic E 6 (R1) Guideline for good clinical practice \u2014 note for guidance on good clinical practice. (1997)."},{"key":"10.1016\/j.contraception.2009.02.016_bib13","series-title":"Lehrbuch der Gyn\u00e4kologie","first-page":"331","article-title":"Zervixkarzinom (Kollumkarzinom, Cacinoma colli uteri, Geb\u00e4rmutterhalskrebs)","author":"Kaiser","year":"1989"},{"key":"10.1016\/j.contraception.2009.02.016_bib14","first-page":"5","article-title":"Statistical methods in cancer research. Volume I \u2014 the analysis of case-control studies","author":"Breslow","year":"1980","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.contraception.2009.02.016_bib15","series-title":"Statistical methods in medical research. 2nd ed","author":"Armitage","year":"1987"},{"key":"10.1016\/j.contraception.2009.02.016_bib16","series-title":"Biopharmaceutical statistics for drug development","article-title":"Clinical efficacy trials with categorical data","author":"Koch","year":"1988"},{"key":"10.1016\/j.contraception.2009.02.016_bib17","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0029-7844(97)00059-8","article-title":"Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial","volume":"89","author":"Redmond","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2009.02.016_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/00016349009021041","article-title":"Ovulation inhibitors containing cyproterone acetate or desogestrel in the treatment of hyperandrogenic symptoms","volume":"69","author":"Erkkola","year":"1990","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2009.02.016_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/09546639809161376","article-title":"The efficacy of oral cyproterone acetate in combination with ethinyloestradiol in acne tarda of the facial type","volume":"9","author":"Gollnick","year":"1998","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.contraception.2009.02.016_bib20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0010-7824(96)00005-4","article-title":"Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris","volume":"53","author":"Mango","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.02.016_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/ejc.6.1.46.53","article-title":"Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate","volume":"6","author":"Vartiainen","year":"2001","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.02.016_bib22","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0190-9622(97)70112-9","article-title":"Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris","volume":"37","author":"Lucky","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.contraception.2009.02.016_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2007.11.003","article-title":"Efficacy and safety of 3 mg drospirenone\/20 mcg ethinylestradiol oral contraceptive administered in 24\/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial","volume":"77","author":"Koltun","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.02.016_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/cjwh.2001.25638","article-title":"Use of a low-dose oral contraceptive containing norethindrone acetate and ethinyl estradiol in the treatment of moderate acne vulgaris","volume":"1","author":"Maloney","year":"2001","journal-title":"Clin J Womens Health"},{"key":"10.1016\/j.contraception.2009.02.016_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/13625180008500411","article-title":"Effect of a desogestrel-containing oral contraceptive on the skin","volume":"5","author":"Katz","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2009.02.016_bib26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0015-0282(01)01938-0","article-title":"A randomized, controlled trial of a low-dose contraceptive containing 20 microg of ethinyl estradiol and 100 microg of levonorgestrel for acne treatment","volume":"76","author":"Thiboutot","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2009.02.016_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.contraception.2007.07.002","article-title":"Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents","volume":"76","author":"Sabatini","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2009.02.016_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1440-0960.1991.tb00683.x","article-title":"An open study of Triphasil and Diane 50 in the treatment of acne","volume":"32","author":"Wishart","year":"1991","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.contraception.2009.02.016_bib29","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing drospirenone or cyproterone acetate on moderate acne and suborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2009.02.016_bib30","first-page":"54","article-title":"A GP's guide to the management of acne in women","volume":"3","author":"Callan","year":"1995","journal-title":"Mod Med Aust"},{"key":"10.1016\/j.contraception.2009.02.016_bib31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2133.1973.tb03009.x","article-title":"Reduction of sebum excretion in man by the antiandrogen, cyproterone acetate","volume":"89","author":"Burton","year":"1973","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.contraception.2009.02.016_bib32","first-page":"29","article-title":"Hirsutism: diagnosis and management","volume":"4","author":"Mercurio","year":"2001","journal-title":"J Gend Specif Med"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782409000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T20:55:19Z","timestamp":1545252919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782409000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0010782409000821"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2009.02.016","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}